2025
SJR Q3
JCR Q4 · 0,9
30 matched articles
SCIE
Journal detail
International Journal of Clinical Pharmacology and Therapeutics
- Publisher
- Dustri-Verlag Dr. Karl Feistle
- Country
- Germany · Western Europe
- Type
- journal
- ISSN
-
09461965
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,287
- Quartile Q3
- H-Index 76
- Cites/doc 0,89
- Docs (3y) 219
- Cites (3y) 192
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 0,9
- 5Y JIF 0,8
- JCI 0,25
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Pharmacology Q3
- Pharmacology (medical) Q3
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,287 | 0,9 | 0,8 | 0,25 | Q4 | 76 |
| 2024 | Q3 | Q4 | 0,264 | 0,7 | 0,7 | 0,26 | Q4 | 74 |
| 2023 | Q3 | Q4 | 0,261 | 0,9 | 0,9 | 0,28 | Q4 | 74 |
| 2022 | Q3 | Q4 | 0,326 | 0,8 | 1,1 | 0,28 | Q4 | 74 |
| 2021 | Q3 | Q4 | 0,356 | 1 | 1,2 | 0,36 | Q4 | 74 |
| 2020 | Q3 | Q4 | 0,363 | 1,4 | 1,3 | 0,36 | Q4 | 74 |
| 2019 | Q3 | Q4 | 0,356 | 0,9 | 0,9 | 0,37 | Q4 | 74 |
| 2018 | — | Q4 | — | 0,9 | 1 | 0,4 | Q4 | — |
| 2017 | Q3 | Q4 | 0,438 | 1,1 | 1,1 | 0,42 | Q4 | 74 |
| 2016 | Q3 | Q4 | 0,387 | 0,9 | 1 | — | — | 74 |
| 2015 | Q3 | Q4 | 0,421 | 1,1 | 1,1 | — | — | 74 |
| 2014 | Q2 | Q4 | 0,471 | 1,2 | 1,2 | — | — | 74 |
| 2013 | Q2 | Q4 | 0,432 | 1 | 1,3 | — | — | 74 |
| 2012 | Q2 | Q4 | 0,403 | 1,2 | 1,4 | — | — | 74 |
| 2011 | Q2 | Q4 | 0,426 | 1,2 | 1,2 | — | — | 74 |
| 2010 | Q2 | Q4 | 0,436 | 1,2 | 1,3 | — | — | 74 |
| 2009 | — | Q3 | — | 1,4 | 1,4 | — | — | — |
| 2008 | — | Q4 | — | 1,3 | 1,5 | — | — | — |
| 2007 | — | Q3 | — | 1,3 | 1,7 | — | — | — |
| 2006 | — | Q3 | — | 1,4 | — | — | — | — |
| 2005 | — | Q3 | — | 1,8 | — | — | — | — |
| 2004 | — | Q3 | — | 1,4 | — | — | — | — |
| 2003 | — | Q3 | — | 0,9 | — | — | — | — |
| 2002 | — | Q3 | — | 1,5 | — | — | — | — |
| 2001 | — | Q3 | — | 1,4 | — | — | — | — |
| 2000 | — | Q3 | — | 1,2 | — | — | — | — |
| 1999 | — | Q3 | — | 0,9 | — | — | — | — |
| 1998 | — | Q3 | — | 0,8 | — | — | — | — |
| 1997 | — | Q4 | — | 0,5 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 321/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 324/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 309/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 261/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 263/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 250/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 248/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 242/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 227/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 228/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 217/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 200/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 205/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 199/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 199/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 192/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 171/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 165/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 147/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 139/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 105/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 114/187 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 137/185 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 98/188 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 95/186 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 97/181 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 110/175 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 114/178 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 133/157 |